Single peptide Vial strength 50 mg
5-Amino-1MQ50 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
5-Amino-1MQ, explained simply
A small synthetic molecule studied in metabolic research. It is often listed alongside peptides, although it is not chemically a peptide.
Research area
Fat metabolism and cellular energy
How it works
Inhibits NNMT, an enzyme involved in nicotinamide metabolism and cellular NAD+ availability.
Why it matters
Researchers are investigating its relationship with fat metabolism and body composition.
What has been observed
In preclinical models, NNMT inhibition has been associated with changes in energy metabolism and fat mass. The same effects have not been established in people.
Effects and points to consider
Reported effects include possible injection-site reactions, headache and temporary nervousness. Long-term human safety data remain limited.
01 / Vial strength 50 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 50 mg 5-Amino-1MQ |
|---|---|
| Final volume | 4 mL |
| Concentration | 12.5 mg/mL |
| One U-100 unit | 125 mcg in 0.01 mL |
Subcutaneous Protocol (4 mL = 12.5 mg/mL)
| Phase | Daily Dose (mg) | Units (per injection) (mL) |
|---|---|---|
| Days 1–2 (Tolerance) | 2.5 mg once daily | 20 units (0.20 mL) |
| Days 3+ (Standard) | 5 mg once daily | 40 units (0.40 mL) |
| Alternative BID | 2.5 mg twice daily | 20 units (0.20 mL) × 2 |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.